Blood Vitamin D Levels Linked to Lower Risk of Ischemic Heart Disease
Higher blood levels of vitamin D are associated with a reduced risk of developing ischemic heart disease, according to a meta-analysis published in Frontiers in Nutrition.
The investigation focused on the primary biomarker for vitamin D status, known as 25-hydroxyvitamin D or 25(OH)D. Individuals with higher concentrations of this marker experienced roughly a 21 percent lower risk of ischemic heart disease compared to those with lower levels. However, the study authors emphasize that these observational results do not prove vitamin D directly protects cardiac tissue against disease.
Carotenoids and Fatty Acids Show Mixed Associations
The analysis also evaluated other nutritional biomarkers, revealing distinct patterns across different compounds. High blood levels of carotenoids showed a 36 percent reduction in the risk of ischemic heart disease. Among fatty acids, linoleic acid displayed a potentially favorable association with heart health.
Conversely, elevated concentrations of palmitic acid and dihomo-gamma-linolenic acid correlated with an increased risk of cardiovascular complications.
Vitamin D metabolites lower cardiovascular disease risk
Over a nine-year follow-up period, 520 participants developed cardiovascular diseases. Participants with the highest levels of the 24,25(OH)₂D₃ metabolite had a 29 percent lower risk of these conditions than those with the lowest levels. Meanwhile, the standard 25(OH)D₃ marker showed a 26 percent risk reduction in this cohort.
Other forms of vitamin D failed to demonstrate a statistically significant connection to cardiovascular disease risk. Genetic analyses from the same cohort indicated potential influences from gene variants involved in vitamin D metabolism, though investigators noted these genetic findings require further validation.
What biomarkers reduce ischemic heart disease risk?
What specific vitamin D biomarker was measured to assess heart disease risk in the general population study?
Researchers analyzed 25-hydroxyvitamin D, also written as 25(OH)D, which serves as the primary clinical indicator of the body’s vitamin D supply. Individuals with higher concentrations of this biomarker showed an approximately 21 percent lower risk of ischemic heart disease.
How much did carotenoid levels reduce the risk of ischemic heart disease in the meta-analysis?
High blood levels of carotenoids were associated with a 36 percent reduction in the risk of ischemic heart disease.
Which specific vitamin D metabolites were tracked in patients with type 2 diabetes?
Investigators measured several metabolites, including 24,25(OH)₂D₃ and 25(OH)D₃, among 1,122 participants with recently diagnosed type 2 diabetes over a nine-year period. Participants with the highest 24,25(OH)₂D₃ levels experienced a 29 percent lower risk of cardiovascular disease.
Earlier research established that vitamin E combined with melatonin reduces pesticide-induced liver damage.
Keep reading